Answers are grounded in this paper and cite their sources.
SUMMARY Overall, anemia increases the risk of mortality only when hemoglobin concentration (Hb) falls below 50 g/L. This effect is magnified by blood losses and cardiovascular disease. No evidence supports a beneficial effect of transfusions in less sick patients and those without cardiovascular disease when Hb is above 70 g/L. Especially in areas of the world where blood transmissible diseases are endemic, the considerable risks of HIV infection nearly always outweigh the benefits of transfusion, even in severely anemic patients. Definitive evidence that minimal Hb greater than 90–100 g/L in patients with cardiovascular disease prevents cardiac morbidity is lacking. Transfusions to improve oxygen transport are definitely not indicated in critically ill adults. Transfusions may be deleterious in patients with several, non‐cardiovascular diagnoses. Conversely, in anemic shock, transfusions allow early withdrawal of supportive therapy. Erythrocyte transfusions improve hemostasis and reduce perioperative complications in patients with sickle cell disease.
No takes yet. Share an insight, caveat, or question.
Hardy et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: